WO2025141521 - LIPIDS HAVING DENDRITIC MOIETIES
National phase entry is expected:
Publication Number
WO/2025/141521
Publication Date
03.07.2025
International Application No.
PCT/IB2024/063236
International Filing Date
27.12.2024
Title **
[English]
LIPIDS HAVING DENDRITIC MOIETIES
[French]
LIPIDES COMPORTANT DES FRACTIONS DENDRITIQUES
Applicants **
SANOFI
Inventors
BAZIN, Emilie
DRIGUEZ, Pierre Alexandre
GARINOT, Marie
KARST, Nathalie
RUIZ, Sophie
VAURE, Celine
Priority Data
23307434.3
29.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6603 | |
| EPO | Filing, Examination, Granting | 26344 | |
| Japan | Filing, Examination, Granting | 2512 | |
| South Korea | Filing, Examination, Granting | 2730 | |
| USA | Filing, Examination, Granting | 12540 |
Total:
50,729
Contact Us
Abstract[English]
Provided herein are dendritic lipids or pharmaceutically acceptable salts thereof. The dendritic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly can be useful for treating various diseases, disorders and conditions, such as those associated with deficiency of one or more proteins.[French]
L'invention concerne des lipides dendritiques ou leurs sels pharmaceutiquement acceptables. Les Iipides dendritiques de l'invention peuvent être utiles pour la délivrance et l'expression d'ARNm et de protéine codée, par exemple, en tant que constituant d'un véhicule de délivrance liposomale, et peuvent par conséquent être utiles pour traiter divers maladies, troubles et affections, comme ceux associés à un déficit en une ou plusieurs protéines.